BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27
• 30
• 31

• 

  Regulatory

  6 FDA Decisions To Watch in Q2 2026

  The FDA has some big verdicts lined up in the second quarter, including one for a closely watched obesity drug that many anticipate will further intensify competition in weight loss.

  March 30, 2026

   · 

  7 min read

   · 

  Tristan Manalac
• Press Releases

  Castle Biosciences’ DecisionDx®-Melanoma Test Significantly Improves Risk Prediction Within AJCC Stages to Support Personalized, Risk-Aligned Management of Cutaneous Melanoma, Data to Be Presented at AAD 2026

  March 30, 2026

   · 

  7 min read
• Press Releases

  Navigator Medicines Advances NAV-240 into Phase 2a and NAV-242 into the Clinic, Supported by New Positive Data Presented at American Academy of Dermatology (AAD) Annual Meeting 2026

  March 30, 2026

   · 

  5 min read
• Press Releases

  Anaptys Announces $100 Million Stock Repurchase Plan and Provides a Business Update

  March 30, 2026

   · 

  5 min read
• Press Releases

  UCB Announces New BIMZELX® (bimekizumab-bkzx) Data at AAD Showing Durable Symptom Control Throughout Three Years in Hidradenitis Suppurativa

  March 30, 2026

   · 

  18 min read
• Press Releases

  Lilly’s EBGLYSS (lebrikizumab-lbkz) delivered up to four years of durable disease control for patients with moderate-to-severe atopic dermatitis

  March 30, 2026

   · 

  15 min read
• Press Releases

  Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

  March 30, 2026

   · 

  5 min read
• Press Releases

  Mayo Clinic receives $75 million gift from Grainger family to transform healthcare logistics

  March 30, 2026

   · 

  2 min read
• Press Releases

  Murad Alam, MD, MSCI, MBA, FAAD, assumes presidency of the American Academy of Dermatology

  March 30, 2026

   · 

  2 min read
• Press Releases

  Dizal’s ZEGFROVY® (Sunvozertinib) Shows Profound Antitumor Activity as First-Line Treatment in Advanced NSCLC Patients with PACC or Other Uncommon Mutations at ELCC 2026

  March 30, 2026

   · 

  6 min read